Three hundred and five billion! In 2020, that was the estimated cost for supporting Alzheimer’s care in the United States. Even with the contribution of unpaid caregivers, the cost is expected to rise to $1 trillion by 2050. Familial caregivers are making a huge contribution to the nation, paying…
Treading Dark Waters
— Ray Burow

“I’ve never been so cold in my life.” I recently visited Washington, D.C., and it was cold — perhaps not by the standards of northern states, but bitter compared with my home in South Florida. Now, I’ve been colder in my life, but the quotation above pumped through my mind…

The Alzheimer’s disease community received fantastic news last week. The U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease. Aside from the apparent reason, the approval of the drug Aduhelm (aducanumab) is encouraging because it’s been nearly two decades since a new treatment for the…
It’s finally happening. We’re digging our way out of a very long and dark tunnel as the U.S. begins to drop COVID-19 restrictions, mainly mask mandates. Also, deaths from the disease have declined here, and fewer people are falling ill from it. As of this writing, more than 61%…
Mental health is an issue that continues to raise concern in the United States. According to an annual report by the nonprofit organization Mental Health America, incidences of anxiety and depression have reached their highest level since the pandemic began last March. Americans are more isolated today than…
Dementia is potentially preventable in more than a third of reported cases, according to the Alzheimer’s Association. This is encouraging, and also surprising. It is hopeful news for anyone who suffers from dementia and for the fight against Alzheimer’s disease. The fact that dementia is preventable may surprise most,…
Loss accompanies Alzheimer’s disease and may create animosity between a caregiver and the person receiving care. A parent or spouse receiving care may become frustrated with their loss of independence, creating an uncomfortable atmosphere that lands resentment squarely upon the caregiver. Adult children who care for aging parents often…
While aging is the greatest risk factor associated with Alzheimer’s disease, the disease is not a normal part of aging. Most people with Alzheimer’s are 65 or older. But this is not an indication that Alzheimer’s is strictly a disease of old age. Thousands of younger people have…
The Alzheimer’s Association cites recruitment for clinical trials, and then retaining those recruits, as one of the greatest obstacles to Alzheimer’s research. Without participants, it is very difficult to find effective treatments. The lack of willing participants is second only to funding for Alzheimer’s research. Clinical studies are key.
The Vietnam War Veterans Recognition Act, signed into law in 2017, designates March 29 of each year as National Vietnam War Veterans Day. In 1973, the last U.S. combat troops pulled out of Vietnam, along with the prisoners of war who were held there. A year later, U.S. President…
The Alzheimer’s Association recently released its 2021 Facts and Figures report. Compared to the 2020 report, there are a few grim changes regarding the most common form of dementia. Primarily, the devastating numbers have gone up. Unsurprising. The United States houses an aging population, and as the number…
Most people only have to contract the flu once to be convinced that skipping a vaccination the next season isn’t a good idea. Cheers to those who choose to avoid the flu, or at least sidestep a full assault, by getting vaccinated before contracting and spreading it. According to the…
‘Tis the season! What season you ask? Well, sure, it’s tax season, but saddling right up next to it is prey on seniors season. This predatory season remains open all year, unfortunately, but the weeks and months leading up to April 15 are rife with scammers who target vulnerable…
Recent Posts
- Oral semaglutide fails to slow Alzheimer’s in pair of clinical trials December 2, 2025
- Canada gives conditional OK to early Alzheimer’s drug Leqembi November 4, 2025
- Kisunla approval offers new option to treat early Alzheimer’s in Europe October 3, 2025
- Guest Voice: A journey through loss, love, and remembrance October 2, 2025
- Leqembi OK’d as under-the-skin autoinjector for early Alzheimer’s September 8, 2025